Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP838832.RA5QYLz7fGbAYm4NGU3jIE8hSHgyiaw6cQBf1fPp0Wtro130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP838832.RA5QYLz7fGbAYm4NGU3jIE8hSHgyiaw6cQBf1fPp0Wtro130_assertion type Assertion NP838832.RA5QYLz7fGbAYm4NGU3jIE8hSHgyiaw6cQBf1fPp0Wtro130_head.
- NP838832.RA5QYLz7fGbAYm4NGU3jIE8hSHgyiaw6cQBf1fPp0Wtro130_assertion description "[They are attractive candidates for liver cancer therapy given that GPC3 and mesothelin show high expression in HCC and CCA, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP838832.RA5QYLz7fGbAYm4NGU3jIE8hSHgyiaw6cQBf1fPp0Wtro130_provenance.
- NP838832.RA5QYLz7fGbAYm4NGU3jIE8hSHgyiaw6cQBf1fPp0Wtro130_assertion evidence source_evidence_literature NP838832.RA5QYLz7fGbAYm4NGU3jIE8hSHgyiaw6cQBf1fPp0Wtro130_provenance.
- NP838832.RA5QYLz7fGbAYm4NGU3jIE8hSHgyiaw6cQBf1fPp0Wtro130_assertion SIO_000772 21942912 NP838832.RA5QYLz7fGbAYm4NGU3jIE8hSHgyiaw6cQBf1fPp0Wtro130_provenance.
- NP838832.RA5QYLz7fGbAYm4NGU3jIE8hSHgyiaw6cQBf1fPp0Wtro130_assertion wasDerivedFrom befree-20150227 NP838832.RA5QYLz7fGbAYm4NGU3jIE8hSHgyiaw6cQBf1fPp0Wtro130_provenance.
- NP838832.RA5QYLz7fGbAYm4NGU3jIE8hSHgyiaw6cQBf1fPp0Wtro130_assertion wasGeneratedBy ECO_0000203 NP838832.RA5QYLz7fGbAYm4NGU3jIE8hSHgyiaw6cQBf1fPp0Wtro130_provenance.